Andromeda Surgical
Andromeda Surgical is a San Francisco-based startup developing autonomous surgical robots to enhance the consistency and efficiency of surgeries, starting with a common urologic procedure.
Company Overview
Andromeda Surgical is based in San Francisco, CA, USA, and operates within the healthcare industry, specifically in the medical devices sub-sector. The company is a part of the Y Combinator S23 batch. With a team size of seven, Andromeda Surgical focuses on developing autonomous surgical robots aimed at enhancing surgical consistency, reducing errors, and improving efficiency. The company is currently in the development stage and does not yet have regulatory approval for commercial sale in the US or any other country.
Technological Innovations
Andromeda Surgical is committed to the development of autonomous surgical robots, integrating AI to revolutionize surgical procedures. The primary aim is to improve consistency, minimize errors, and boost efficiency in surgeries. Although the product is still under development and awaiting regulatory approval, Andromeda Surgical's innovative approach is focused on a common urologic procedure as the starting point for its technological advancements.
Locations and Regions
Andromeda Surgical is headquartered in San Francisco, CA, USA. The company primarily targets the markets within the United States and the broader regions of America and Canada. Being situated in a major technological hub like San Francisco positions the company advantageously in terms of access to cutting-edge research, talent, and industry insights.
Y Combinator Involvement
Andromeda Surgical is part of the Y Combinator S23 batch. Inclusion in this prestigious accelerator program provides the company with valuable resources, mentorship, and networking opportunities, which are critical during its early development phases. Being part of Y Combinator supports the company's mission to innovate within the healthcare industry.
